US-HEALTH-VIRUS

In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
US-HEALTH-VIRUS
COMPRAR UMA LICENÇA
Como posso usar esta imagem?
R$ 3.000,00
BRL

DETALHES

Restrições:
Contacte o representante local para todos os usos comerciais ou promocionais. Direitos editoriais totais no Reino Unido, EUA, Irlanda, Itália, Espanha, Canadá (não inclui o Quebec). Direitos editoriais restritos em qualquer outro local; contacte o representante local.
Crédito:
OLIVIER DOULIERY / Colaborador
ID Editorial:
1208237136
Coleção:
AFP
Data da criação:
25 de março de 2020
Data do upload:
Tipo de licença:
Info sobre autorização:
Sem autorização Mais informações
Fonte:
AFP
Código de barras:
AFP
Nome do objeto:
AFP_1Q67SP
Tamanho máximo do arquivo:
4000 x 2507 px (33,87 x 21,23 cm) - 300 dpi - 2 MB